Navigation Links
U.S. Commerce Secretary Gutierrez to Address AdvaMed 2007

Plenary Speaker Hall of Fame Coach Jim Calhoun

Credits Early Diagnosis with Saving his Life

WASHINGTON, Oct. 2 /PRNewswire-USNewswire/ -- Day two of AdvaMed 2007: The MedTech Conference will highlight how everyday patients are heroes and benefit from advancements in medical technology as well as speakers on the diversity and strength of the economic impact of the medical technology sector. The conference runs Oct. 1 through Oct. 3.

Co-writing "A PASSION TO LEAD: Seven Leadership Secrets for Success in Business, Sports, and Life" is the latest endeavor by Hall of Fame Coach and prostate cancer survivor, Jim Calhoun. Calhoun, one of the most successful coaches ever in college basketball history with two national championships at the University of Connecticut, credits early diagnosis and a successful surgery with his speedy recovery from prostate cancer. During his plenary remarks, Calhoun will address a series of life goals he set for himself as a coach, teacher, and family man, as well as his secrets for success on and off the court. He will provide anecdotes from his life and career including his successful battle against prostate cancer and his support for cardiovascular research.

"Coach Calhoun is not just a great basketball coach and strategist; he is an inspiration, role model and exceptional leader. He is helping to save lives by encouraging regular cancer screenings," said Stephen J. Ubl, president and CEO of AdvaMed.

U.S. Rep. Lois Capps (D-Calif.) also will speak before AdvaMed 2007 participants.

U.S. Commerce Secretary Carlos M. Gutierrez will speak at 5:15 p.m. Following the Secretary's comments, members of the Global Harmonization Task Force and the AdvaMed 2007 conference will participate in a joint gala reception in which Speaker of the House Nancy Pelosi is an invited honoree.

Other panels of note include:

8:30 to 9 a.m. - Can International Harmonization Ever Be Achieved? With Dr. Larry Kessler, Director of the Office of Science and Engineering Laboratories at the Food and Drug Administration.

10:45 a.m. to 12:15 p.m. - Value of Medical Technology: Innovation, Patients, Society with Dr. Thomas J. Fogarty; Frank R. Lichtenberg, Ph.D.; Courtney Brown, professor of business at Columbia University; Dr. Martin M. Malawer, Professor of Orthopedic Surgery at Washington Hospital Center; Uwe E. Reindhardt, Ph.D., Professor of Economics and Public Affairs, Princeton University.

2 p.m. to 3 p.m. - Fostering Innovation from the Executive Office: With Gregory C. Simon, President of Faster Cures/The Center for Accelerating Medical Solutions; James V. Mazzo, Chairman, President and CEO of Advanced Medical Optics, Inc.; Scott Garrett, President and CEO of Beckman Coulter; Martin Emerson, CEO, American Medical Systems; and Michael Minogue, CEO, ABIOMED.

2 p.m. to 3:30 p.m., Health Reform with moderator Laurie McGinley, The Wall Street Journal; Ron Pollack, Families USA; Robert Moffit, Ph.D., The Heritage Foundation; Len Nichols, The New America Foundation; and Chip N. Kahn III, Federation of American Hospitals.

2 p.m. to 3:30 p.m., Emerging Opportunities for Medical Devices used in Advanced Therapies, Dr. Lydia Villa-Komaroff, President of Cytonome, Inc; Paul LaViolette, COO of Boston Scientific Corporation; David Perez, President of Gambro BCT; Joseph Hogan, President and CEO of GE Healthcare; and Harlan Weisman, M.D., Chief Science and Technology Officer of Johnson & Johnson Medical Devices and Diagnostics.

3.45 p.m. to 5:15 p.m., The Future of Health Entitlements moderated by Mary Agnes Carey of Congressional Quarterly, Kenneth Thorpe, Professor and Chair, Rollins School of Public Health; former U.S. Rep. Nancy Johnson, and Peter Orszag, Congressional Budget Office.

About AdvaMed:

AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. Our members produce nearly 90 percent of the health care technology purchased annually in the United States and more than 50 percent purchased annually around the world. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit

About AdvaMed 2007:

AdvaMed 2007 is the premier medical technology conference and exhibition for business leaders, policymakers, investors, news media, patient advocates, and industry stakeholders from around the world. This year's conference offers a variety of workshops and panel discussions on subjects such as Medicare reimbursement, compliance, intellectual property, global market opportunities, corporate finance, public policy, emerging company issues, 21st century health care and the value of medical technology.

Whether you need to finance, partner or license technology, AdvaMed 2007 introduces you to key decision-makers featuring a business development partnering program, company presentations, and an exhibition showcasing the latest medical technologies and products. Attendees have the opportunity to directly access key players, inform stakeholders as to the progress of our industry, and influence the business, political and financial climates so imperative to innovation.

For more information, visit or call 1-202-434-7213.

SOURCE AdvaMed and AdvaMed 2007
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Perscitus Biosciences secures $250K Commerce loan
2. Stem cell and regenerative medicine center to aid education and commerce
3. Commerce qualifies seven for investor tax credits
4. E-commerce firm brings 700 jobs to Eau Claire
5. T.E.C. Center to receive Commerce grant
6. Commerce secretary Mary Burke on innovation, expansion and BIO
7. Secretary Nettles leaving Commerce for law practice
8. Irish flute passion drives e-commerce spirit for Eaton techie
9. Tech companies get commerce loans for new ventures
10. Eight tech companies get Commerce grants
11. Madison biotechs get Commerce grants
Post Your Comments:
(Date:10/13/2015)... -- PharmaCyte Biotech, Inc. (OTCQB: PMCB) shares closed at $.1035, ... average with 1,308,352 shares being traded. PMCB shares have been ... low of $.072 in September, then bouncing back to current ... due diligence will show investors in PharmaCyte Biotech, Inc. information ... using the link below at no cost. ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... and assessment of organotypic 3D cell culture models, has launched a 14 ... in their patent-pending 3D InSightâ„¢ Human Liver Microtissues. The service streamlines toxicity ...
(Date:10/13/2015)... , ... October 13, 2015 , ... ... President. Steve joins as the Pistoia Alliance continues to drive to increase the ... non-profit Pistoia Alliance is focusing its vision and expanding its work in supporting ...
(Date:10/13/2015)... Oct. 13 2015 Research and Markets( ... & Europe Markets for Bone Morphogenetic Protein Growth Factor ... offering. --> --> ... the formation of bone after a fracture. In nature, ... in the formation of the skeleton. There are twenty ...
Breaking Biology Technology:
(Date:9/28/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ), ... that Lenovo has selected Synaptics , Natural ID ... latest smartphone, the Vibe P1. The new Vibe ... device and provide swift access to applications and mobile ... ID FS4202 sensor solution utilizes AES256-bit encryption of the ...
(Date:9/24/2015)... , Sept. 24, 2015  EyeLock LLC, a ... showcasing its award winning and latest technology in Booth ... Anaheim, California . EyeLock,s iris authentication ... with unmatched biometric accuracy, making it the most proven ... platform uses video technology to deliver a fast and ...
(Date:9/10/2015)... This report provides detailed descriptions of the sensor types ... types that will dominate in the future. Many product ... technology hype curve in the last five years before ... all of them is the prominence of sensor options ... Sensors collect data about the physical and chemical properties ...
Breaking Biology News(10 mins):